JS, T., Z, T., M, L., M, Y., A, W., X, H., . . . JC, G. (2024). Insights into biofilm architecture and maturation enable improved clinical strategies for exopolysaccharide-targeting therapeutics. Cell chemical biology, 31(12), 2096. https://doi.org/10.1016/j.chembiol.2024.11.005
Chicago Style (17th ed.) CitationJS, Temme, Tan Z, Li M, Yang M, Wlodawer A, Huang X, Schneekloth JS Jr, and Gildersleeve JC. "Insights into Biofilm Architecture and Maturation Enable Improved Clinical Strategies for Exopolysaccharide-targeting Therapeutics." Cell Chemical Biology 31, no. 12 (2024): 2096. https://doi.org/10.1016/j.chembiol.2024.11.005.
MLA (9th ed.) CitationJS, Temme, et al. "Insights into Biofilm Architecture and Maturation Enable Improved Clinical Strategies for Exopolysaccharide-targeting Therapeutics." Cell Chemical Biology, vol. 31, no. 12, 2024, p. 2096, https://doi.org/10.1016/j.chembiol.2024.11.005.